Skip to main content
Clinical Trials/NCT04175938
NCT04175938
Recruiting
Phase 1

Assessment of Corneal Endothelial Function Following Hypoxic Stress

Massachusetts Eye and Ear Infirmary1 site in 1 country20 target enrollmentDecember 1, 2025

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Fuchs' Endothelial Corneal Dystrophy
Sponsor
Massachusetts Eye and Ear Infirmary
Enrollment
20
Locations
1
Primary Endpoint
Time to full recovery from swelling
Status
Recruiting
Last Updated
7 months ago

Overview

Brief Summary

The purpose of this study is to determine the difference in the cornea's response to contact lens placement between healthy and unhealthy eyes. The amount of corneal swelling (corneal thickness) between normal and FECD patients before and after a stress test will be measured and compared.

Detailed Description

Clarity of the cornea is essential for optimal vision. The endothelium is a layer within the cornea that controls its clarity. Fuchs endothelial corneal dystrophy (FECD) is a progressive disease that affects both eyes in which the endothelium is dysfunctional, causing the cornea to swell and lose its clarity. Because of the vision loss associated with this swelling, corneal transplantation is needed for patients with advanced FECD. Currently, there is no method to directly measure how well endothelium cells are functioning in patients with FECD. Such a measurement, if it were possible, would allow physicians to identify patients who are at a higher risk of corneal swelling. The goal of this study is to establish a tool to measure and compare the amounts of corneal swelling between normal and FECD patients after a stress test is performed (the wearing of an FDA-approved contact lens.) Data will also be collected regarding how quickly and how well a cornea recovers from swelling in patients with healthy eyes compared to those with FECD.

Registry
clinicaltrials.gov
Start Date
December 1, 2025
End Date
November 30, 2027
Last Updated
7 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ula Jurkunas

Associate Professor, Harvard Medical School

Massachusetts Eye and Ear Infirmary

Eligibility Criteria

Inclusion Criteria

  • Subjects in the Fuch's Dystrophy arm of the study must meet following criteria:
  • Have a clinical diagnosis of Fuchs endothelial corneal dystrophy
  • Be scheduled for corneal transplantation in the next 6 months
  • Have no history of prior ocular surgery in study eye
  • Have no history of contact lens intolerance
  • Be motivated and willing to complete ocular imaging tests
  • Subjects in the healthy eyes arm of the study must meet following criteria:
  • Have no prior history of ocular disease including ocular surface disease or glaucoma
  • Have no history of prior ocular surgery in study eye
  • Have no history of contact lens intolerance

Exclusion Criteria

  • Pregnant women

Outcomes

Primary Outcomes

Time to full recovery from swelling

Time Frame: three hours

The time it takes for the eye to no longer be swollen

Thickness of the cornea before and after the stress test

Time Frame: seven hours

Maximum changes in the thickness of the cornea measured before and after the stress test

The rate of corneal recovery after the stress test

Time Frame: three hours

The extent of swelling evident at regular intervals during the 3 hours after the stress test

Study Sites (1)

Loading locations...

Similar Trials